Cargando…

Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil in Japanese patients with lupus nephritis

BACKGROUND: Mycophenolate mofetil (MMF), a prodrug of the immunosuppressive agent mycophenolic acid (MPA), is difficult to administer because of the pharmacokinetic complexity of MPA. Although dosage adjustment according to the 12-h area under the concentration–time curve (AUC(0-12)) is thought to b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mizaki, Tomoko, Nobata, Hironobu, Banno, Shogo, Yamaguchi, Makoto, Kinashi, Hiroshi, Iwagaitsu, Shiho, Ishimoto, Takuji, Kuru, Yukiko, Ohnishi, Masafumi, Sako, Ken-ichi, Ito, Yasuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830922/ https://www.ncbi.nlm.nih.gov/pubmed/36624529 http://dx.doi.org/10.1186/s40780-022-00271-w

Ejemplares similares

Case report: Thrombotic microangiopathy concomitant with macrophage activation syndrome in systemic lupus erythematosus refractory to conventional treatment successfully treated with eculizumab
por: Yamaguchi, Makoto, et al.
Publicado: (2023)

Association between sinusitis and relapse and changes in the myeloperoxidase–antineutrophil cytoplasmic antibody in microscopic polyangiitis
por: Tanaka, Hiroya, et al.
Publicado: (2020)

Oral candidiasis is a significant predictor of subsequent severe infections during immunosuppressive therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Yamaguchi, Makoto, et al.
Publicado: (2019)

Association between body mass index and severe infection in older adults with microscopic polyangiitis: a retrospective cohort in Japan
por: Sugiyama, Hirokazu, et al.
Publicado: (2021)

Association between serum magnesium levels and abdominal aorta calcification in patients with pre-dialysis chronic kidney disease stage 5
por: Ito, Mayumi, et al.
Publicado: (2021)

Association between renal-limited vasculitis and relapse of antineutrophil cytoplasmic antibody-associated vasculitis: A single-center retrospective cohort study in Japan
por: Yamaguchi, Makoto, et al.
Publicado: (2022)

Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008)

Association of alcohol consumption with the incidence of proteinuria and chronic kidney disease: a retrospective cohort study in Japan
por: Tanaka, Akio, et al.
Publicado: (2022)

Treatment of Class IV Lupus Nephritis with Mycophenolate Mofetil Monotherapy
por: Nawata, Takashi, et al.
Publicado: (2018)

Relationship between doses of antihypertensive drugs and left ventricular mass index changes in hemodialysis patients in a Japanese cohort
por: Kitamura, Fumiya, et al.
Publicado: (2021)

Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Lupus Nephritis by Using Mycophenolate Mofetil
por: Nawata, Takashi, et al.
Publicado: (2017)

Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)

Use of mycophenolate mofetil (MMF) in lupus nephritis (LN) in children
por: Indaco, R, et al.
Publicado: (2008)

Successful Treatment with Mycophenolate Mofetil and Tacrolimus in Juvenile Severe Lupus Nephritis
por: Kise, Tomoo, et al.
Publicado: (2015)

Efficacy of long-term maintenance therapy with mycophenolate mofetil in lupus nephritis
por: Rezaieyazdi, Zahra, et al.
Publicado: (2014)

The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritis
por: Hackl, A., et al.
Publicado: (2023)

The development of membranous lupus nephritis during treatment with mycophenolate mofetil for proliferative renal disease
por: Dalton, Kristen, et al.
Publicado: (2010)

Combination of tacrolimus and mycophenolate mofetil in persistent proteinuria due to refractory childhood lupus nephritis
por: Almutairi, Abdulaziz, et al.
Publicado: (2018)

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
por: Houssiau, Frédéric A, et al.
Publicado: (2010)

Lymphopenia is a risk factor for severe infections in older patients with microscopic polyangiitis: a retrospective cohort study in Japan
por: Yamaguchi, Makoto, et al.
Publicado: (2023)

Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis
por: Moore, R Andrew, et al.
Publicado: (2006)

Addition of cyclosporine/tacrolimus for pediatric relapsed lupus nephritis during mycophenolate mofetil maintenance therapy
por: Mao, Youying, et al.
Publicado: (2018)

Mycophenolate mofetil in the treatment of Chinese patients with lupus nephritis: A PRISMA-compliant meta-analysis
por: Zhang, Haitao, et al.
Publicado: (2020)

Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis
por: Tamirou, Farah, et al.
Publicado: (2016)

Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study
por: Laskari, Katerina, et al.
Publicado: (2010)

Efficacy of High-Dose Mycophenolate Mofetil in Multitarget Therapy for Lupus Nephritis: Two Consecutive Case Reports
por: Furuto, Yoshitaka, et al.
Publicado: (2020)

Neuropsychiatric Systemic Lupus Erythematosus with Cerebral Vasculitis and Lupus Nephritis Successfully Treated with High-dose Glucocorticoids and Mycophenolate Mofetil
por: Tanaka, Saki, et al.
Publicado: (2022)

Mycophenolate mofetil for the treatment of Henoch-Schönlein purpura nephritis; current knowledge and new concepts
por: Nickavar, Azar, et al.
Publicado: (2017)

Cost-Utility Analysis of Mycophenolate Mofetil versus Azathioprine Based Regimens for Maintenance Therapy of Proliferative Lupus Nephritis
por: Nee, Robert, et al.
Publicado: (2015)

Comparison of the Effectiveness and Safety of Mycophenolate Mofetil and Cyclophosphamide in Lupus Nephritis: Evidence from a Real-World Study
por: Zhang, Xiaohui, et al.
Publicado: (2023)

Mycophenolate Mofetil in a Lupus Patient with Pulmonary Hypertension
por: Machireddy, Kirthi, et al.
Publicado: (2018)

Clinical Outcomes Observed among Biopsy Proven Lupus Nephritis Patients Treated with Mycophenolate Mofetil as First-line Therapy
por: Timlin, Homa, et al.
Publicado: (2017)

Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review
por: Margiotta, Domenico Paolo Emanuele, et al.
Publicado: (2018)

Comparative efficacy and safety of mycophenolate mofetil and cyclophosphamide in the induction treatment of lupus nephritis: A systematic review and meta-analysis
por: Jiang, Yue-Peng, et al.
Publicado: (2020)

Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
por: Marques, R, et al.
Publicado: (2010)

Mycophenolate Mofetil Use in Severe Myocarditis Complicating Systemic Lupus
por: Allaoui, Abire, et al.
Publicado: (2022)

Severe Enteropathy From Mycophenolate Mofetil
por: Jehangir, Asad, et al.
Publicado: (2016)

Autoimmune Gastritis Treated With Mycophenolate Mofetil
por: Harb, Ali H., et al.
Publicado: (2020)

Mycophenolate mofetil: Cytopenia: case report
Publicado: (2021)

Mycophenolate mofetil in giant cell arteritis
por: Pankow, Anne, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_plgij584ljdmtj25ghrqv5gkdd